SEC Comment Letter for CytoDyn Inc. (CYDY) (CIK 0001175680) (CYDY) — Oct 11, 2016
CytoDyn Inc. (CYDY) (CIK 0001175680)
Date: Oct. 11, 2016 · CIK: 0001175680 · Accession: 0000000000-16-096522
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-213866
Letter
Mail Stop 4546 October 7 , 2016 Nader Pourhassan, Ph.D. President and Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660
Re: CytoDyn Inc. Registration Statement on Form S-3 Filed September 29, 2016 File No. 333-213866
Dear Dr. Pourhassan :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at (202) 551 -2544 with any questions.
Sincerely,
/s/ Mary Beth Breslin for
Show Raw Text
Mail Stop 4546 October 7 , 2016 Nader Pourhassan, Ph.D. President and Chief Executive Officer CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver, Washington 98660 Re: CytoDyn Inc. Registration Statement on Form S-3 Filed September 29, 2016 File No. 333-213866 Dear Dr. Pourhassan : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at (202) 551 -2544 with any questions. Sincerely, /s/ Mary Beth Breslin for Suzanne Hayes Assistant Director Office of Healthcare and Insurance cc: Steven Skolnick , Esq. Lowenstein Sandler, LLP